• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

MASLD: predictive value for liver-related events and extra-hepatic complications.

作者信息

Jamalinia Mohamad, Lonardo Amedeo

机构信息

Gastroenterohepatology Research Center, Shiraz University of Medical Sciences, Shiraz, Iran.

Department of Internal Medicine, Azienda Ospedaliero-Universitaria of Modena (-2023), Modena, Italy.

出版信息

Expert Rev Gastroenterol Hepatol. 2024 Nov;18(11):685-688. doi: 10.1080/17474124.2024.2435504. Epub 2024 Dec 1.

DOI:10.1080/17474124.2024.2435504
PMID:39618190
Abstract
摘要

相似文献

1
MASLD: predictive value for liver-related events and extra-hepatic complications.代谢相关脂肪性肝病（MASLD）：对肝脏相关事件和肝外并发症的预测价值
Expert Rev Gastroenterol Hepatol. 2024 Nov;18(11):685-688. doi: 10.1080/17474124.2024.2435504. Epub 2024 Dec 1.
2
Systemic impacts of metabolic dysfunction-associated steatotic liver disease (MASLD) and metabolic dysfunction-associated steatohepatitis (MASH) on heart, muscle, and kidney related diseases.代谢功能障碍相关脂肪性肝病（MASLD）和代谢功能障碍相关脂肪性肝炎（MASH）对心脏、肌肉和肾脏相关疾病的全身影响。
Front Cell Dev Biol. 2024 Jul 16;12:1433857. doi: 10.3389/fcell.2024.1433857. eCollection 2024.
3
Impact of Weight Loss on Metabolic Dysfunction Associated Steatohepatitis and Hepatic Fibrosis.体重减轻对代谢功能障碍相关脂肪性肝炎和肝纤维化的影响。
Curr Diab Rep. 2025 Feb 18;25(1):23. doi: 10.1007/s11892-025-01579-1.
4
Cardiovascular Risk Reduction in Metabolic Dysfunction-Associated Steatotic Liver Disease and Metabolic Dysfunction-Associated Steatohepatitis.代谢功能障碍相关脂肪性肝病和代谢功能障碍相关脂肪性肝炎中心血管风险的降低
Curr Cardiol Rep. 2025 Jan 18;27(1):28. doi: 10.1007/s11886-024-02185-5.
5
BRUCE liver-deficiency potentiates MASLD/MASH in PTEN liver-deficient background by impairment of mitochondrial metabolism in hepatocytes and activation of STAT3 signaling in hepatic stellate cells.BRUCE肝脏缺乏通过损害肝细胞中的线粒体代谢和激活肝星状细胞中的STAT3信号通路，在PTEN肝脏缺乏背景下增强了代谢相关脂肪性肝病/非酒精性脂肪性肝炎。
bioRxiv. 2024 Sep 14:2024.09.13.611500. doi: 10.1101/2024.09.13.611500.
6
Improvement of MASLD and MASH by suppression of hepatic N-acetyltransferase 10.通过抑制肝 N-乙酰基转移酶 10 改善 MASLD 和 MASH。
Mol Metab. 2024 Nov;89:102030. doi: 10.1016/j.molmet.2024.102030. Epub 2024 Sep 16.
7
EASL-EASD-EASO Clinical Practice Guidelines on the management of metabolic dysfunction-associated steatotic liver disease (MASLD): Executive Summary.EASL-EASD-EASO 临床实践指南：代谢功能障碍相关脂肪性肝病（MASLD）的管理。执行摘要。
Diabetologia. 2024 Nov;67(11):2375-2392. doi: 10.1007/s00125-024-06196-3.
8
Prognostic value of metabolic dysfunction-associated steatotic liver disease over coronary computed tomography angiography findings: comparison with no-alcoholic fatty liver disease.代谢相关脂肪性肝病与冠状动脉 CT 血管造影结果的预后价值比较：与非酒精性脂肪肝的比较。
Cardiovasc Diabetol. 2024 May 10;23(1):167. doi: 10.1186/s12933-024-02268-1.
9
One-hour post-load glucose is associated with biopsy-proven metabolic dysfunction-associated steatotic liver disease in obese individuals.负荷后1小时血糖与肥胖个体中经活检证实的代谢功能障碍相关脂肪性肝病有关。
Diabetes Metab. 2025 Jan;51(1):101588. doi: 10.1016/j.diabet.2024.101588. Epub 2024 Dec 5.
10
ACMSD inhibition corrects fibrosis, inflammation, and DNA damage in MASLD/MASH.ACMSD抑制可纠正代谢相关脂肪性肝病/非酒精性脂肪性肝炎中的纤维化、炎症和DNA损伤。
J Hepatol. 2025 Feb;82(2):174-188. doi: 10.1016/j.jhep.2024.08.009. Epub 2024 Aug 22.

引用本文的文献

1
Non-Alcoholic Fatty Liver Disease in Everyday Clinical Practice: From Diagnosis to Therapy.日常临床实践中的非酒精性脂肪性肝病：从诊断到治疗
Life (Basel). 2025 Feb 25;15(3):363. doi: 10.3390/life15030363.